U.S. market Closed. Opens in 5 hours 51 minutes

BOLD | Boundless Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue957.00K942.00K682.00KN/AN/AN/A
Gross Profit-957.00K-942.00K-682.00KN/AN/AN/A
Operating Expenses54.80M46.47M25.30M134.37M93.18M60.05M
Selling, General & Admin12.16M9.31M6.02M30.00M17.27M11.28M
Research & Development41.68M37.16M19.28M104.37M75.90M48.77M
Other Operating ExpensesN/A-100.00K-5.00KN/AN/AN/A
Operating Income-54.80M-46.47M-25.30M-134.37M-93.18M-60.05M
Other Expenses / Income5.36M568.00K91.00K5.55M693.00K378.00K
Before Tax Income-49.43M-45.90M-25.21M-128.82M-92.48M-59.67M
Income Tax ExpensesN/A-668.00K-96.00K5.55M-2.25M378.00K
Net Income-49.43M-45.90M-25.21M-128.82M-90.24M-59.67M
Interest ExpensesN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding22.24M22.24M22.24M44.03M44.03M44.03M
Diluted Shares Outstanding22.24M22.24M22.24M44.03M26.58M10.67M
EBITDA-48.48M-45.53M-24.62M-121.36M-88.74M-58.09M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-49.43M-46.57M-25.31M-123.27M-92.48M-59.29M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙